A prospective observational study to clarify the real-world evidence for relapsed acute lymphoblastic leukemia in children, adolescents and young adults

A prospective observational study to clarify the real-world evidence for relapsed acute lymphoblastic leukemia in children, adolescents and young adults - ALL-R23

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055169

Enrollment

110

Registered

2024-08-30

Start date

2024-08-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

relapsed acute lymphoblastic leukemia in children, adolescents and young adults

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Relapsed acute lymphoblastic leukemia Must be under 25 years of age at the time consent is obtained. Must have been enrolled in the CHM-14 study. Be enrolled in this study for the first time Have written consent to participate in this study from the patient or a legal representative.

Exclusion criteria

Exclusion criteria: In case the principal investigator or research assignee determines that participation in this study is not appropriate.

Design outcomes

Primary

Measure	Time frame
Event free survival	—

Countries

Japan

Contacts

Public ContactHidemi Toyoda

Mie University Hospital Department of Pediatrics

htoyoda@med.mie-u.ac.jp81592321111

Outcome results